We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+7.88%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.49B
AUM Growth
+$51.2M
Cap. Flow
-$31.6M
Cap. Flow %
-2.12%
Top 10 Hldgs %
36.37%
Holding
159
New
26
Increased
22
Reduced
60
Closed
36

Sector Composition

Rank Sector Weight
1 Technology 23.5%
2 Financials 18.64%
3 Consumer Discretionary 18.2%
4 Healthcare 18.05%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
51
Vertex Pharmaceuticals
VRTX
$130B
$9.56M 0.64%
62,882
-1,500
-2% -$226K
GWPH
52
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$8.72M 0.58%
85,971
+38,000
+79% +$4.07M
TSLX icon
53
Sixth Street Specialty
TSLX
$1.7B
$8.4M 0.56%
400,563
+101,400
+34% +$2.1M
BSX icon
54
Boston Scientific
BSX
$63.6B
$7.51M 0.5%
257,400
LKFT
55
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$7.37M 0.49%
72,453
+2,600
+4% +$227K
PCRX icon
56
Pacira BioSciences
PCRX
$960M
$6.9M 0.46%
183,800
+164,300
+843% +$6.61M
CLVS
57
DELISTED
Clovis Oncology, Inc.
CLVS
$6.9M 0.46%
83,735
+73,200
+695% +$5.8M
SCI icon
58
Service Corp International
SCI
$11.1B
$6.89M 0.46%
199,668
-31,200
-14% -$1.08M
TPH
59
DELISTED
Tri Pointe Homes
TPH
$6.87M 0.46%
497,271
-28,000
-5% -$372K
HOLX
60
DELISTED
Hologic
HOLX
$6.33M 0.42%
172,548
-47,300
-22% -$1.91M
BZUN
61
Baozun
BZUN
$159M
$6.25M 0.42%
+190,900
New +$6.04M
CHCT
62
Community Healthcare Trust
CHCT
$420M
$6.21M 0.42%
230,500
CORV
63
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$6.13M 0.41%
2,878,985
MSCC
64
DELISTED
Microsemi Corp
MSCC
$5.82M 0.39%
+113,100
New +$5.69M
DERM
65
DELISTED
Dermira, Inc.
DERM
$5.76M 0.39%
213,385
+31,600
+17% +$827K
XRN
66
Chiron Real Estate Inc
XRN
$478M
$5.61M 0.38%
125,000
EPI icon
67
WisdomTree India Earnings Fund ETF
EPI
$1.95B
$5.54M 0.37%
220,300
-73,400
-25% -$1.91M
KERX
68
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$5.33M 0.36%
751,101
+488,800
+186% +$3.51M
AGN
69
DELISTED
Allergan plc
AGN
$5.18M 0.35%
25,300
-11,100
-30% -$2.58M
CABO icon
70
Cable One
CABO
$106M
$5.06M 0.34%
7,012
+4,200
+149% +$3.1M
ES icon
71
Eversource Energy
ES
$25.3B
$5.01M 0.34%
82,900
D icon
72
Dominion Energy
D
$56.2B
$4.92M 0.33%
64,000
OPTU
73
Optimum Communications Inc
OPTU
$377M
$4.88M 0.33%
178,700
-9,000
-5% -$275K
WVE icon
74
Wave Life Sciences
WVE
$879M
$4.54M 0.3%
208,703
+15,800
+8% +$318K
BMRN icon
75
BioMarin Pharmaceuticals
BMRN
$12.5B
$4.53M 0.3%
48,645
-1,500
-3% -$133K

Similar funds

Clough Capital Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Clough Capital Partners held 159 positions worth $1.49B, up 3.5% from $1.44B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Clough Capital Partners's Q3 2017 filing shows 26 new, 22 increased, 60 reduced and 36 closed positions. Its largest new stake was Cypress Semiconductor: 1,695,300 shares worth $25.5M. The largest sale was Western Digital, an estimated $26.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Clough Capital Partners's largest Q3 2017 buy was Cypress Semiconductor: 1,695,300 shares worth $25.5M.
  • Clough Capital Partners added most to Lam Research in Q3 2017, an estimated $32.7M increase.
  • Clough Capital Partners's biggest Q3 2017 reduction was Apple, cutting an estimated $19.2M.
  • Clough Capital Partners fully exited Western Digital in Q3 2017, selling an estimated $26.7M.
  • Clough Capital Partners's ten largest holdings make up 36% of its $1.49B portfolio in Q3 2017.
  • Clough Capital Partners opened 26 new positions and closed 36 in Q3 2017.
  • Clough Capital Partners's portfolio value rose 3.5% quarter-over-quarter to $1.49B.

Based on Clough Capital Partners's 13F filing for Q3 2017, filed 14 Nov 2017.